Brief: Senti Biosciences Announces Holding Company Reorganization Effective By April 16, 2026 - SEC Filing
April 1 (Reuters) - Senti Biosciences, Inc SNTI.O: SENTI BIOSCIENCES INC - ANNOUNCES HOLDING COMPANY REORGANIZATION EFFECTIVE BY APRIL 16, 2026 - SEC FILING SENTI BIOSCIENCES, INC: UPON EFFECTIVENESS OF HOLDING COMPANY REORGANIZATION, SENTI BIOSCIENCES HOLDINGS WOULD BECOME SUCCESSOR ISSUER TO CO Source text: [ID:n0001628280-26-022824] Further company coverage: SNTI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Senti Biosciences Holdings
See all newsBrief: Senti Biosciences Says Offering 15.97 Million Shares Of Common Stock For Resale By Selling Securityholder
Senti Biosciences Q1 net loss narrows on cost reduction
Brief: Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy
Brief: Senti Biosciences Announces Holding Company Reorganization Effective By April 16, 2026 - SEC Filing
Senti Biosciences Q4 revenue misses analyst estimates